Home > Products > malaria antigen & TLR1 > Recombinant Anti-malaria antigen x Anti-TLR1 Bispecific Antibody (scFv-CH1/CL)

Recombinant Anti-malaria antigen x Anti-TLR1 Bispecific Antibody (scFv-CH1/CL)  (BSCC-181)

Recombinant Anti-malaria antigen x Anti-TLR1 Bispecific Antibody (scFv-CH1/CL) is designed to be expressed as two chains. One scFv from an anti-malaria antigen antibody variable domain is fused to CH1 and the other scFv from an anti-TLR1 antibody variable domain fused to CL, or vice versa. And the CH1 and CL domains are linked covalently via a natural disulfide bond. This BsAb can retarget professional antigen-presenting cells (APCs) including DCs or NK cells to malaria antigen. It is designed for the research of Malaria therapy.

Specifications

Targets
malaria antigen & TLR1
Type
scFv-based Bispecific Fragments
Species Reactivity
Human
Target 1
malaria antigen
Host Animal 1
Mouse
Target 2
TLR1
Host Animal 2
Mouse
Application
FuncS; Promising therapeutic agent
Related Disease
Malaria

Targets

Target 1
malaria antigen
Alternative Names
malaria antigen; parasitic protozoans
Target 2
TLR1
Gene ID
UniProt ID
Alternative Names
CD281; TIL; TIL. LPRS5; rsc786; TLR1; Toll-like receptor 1; TLR

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-malaria antigen x Anti-TLR1 Bispecific Antibody (scFv-CH1/CL) (BSCC-181). Click the button below to contact us or submit your feedback about this product.

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Welcome! For price inquiries, we will get back to you as soon as possible.

To order, please email

INQUIRY
Related products of "malaria antigen & TLR1"
Online Inquiry

24x7 Service quality
USA

Tel:
Fax:
Email:

UK

Tel:
Email:

Germany

Tel:
Email: